collaborators were supplied with duplicate powdered composites of levodopa ( 1 synthetic formulation , 1 commercial tablet , and 1 commercial capsule ) and levodopa-carbidopa ( 1 synthetic formulation and 2 commercial tablets ) , along with individual levodopa-carbidopa tablets for content uniformity determinations .
C0023570
levodopa
C0353697
with